IL18 and hyperlipidemia: Our data confirmed that increased hyperlipidemia-mediated inflammation activated HMGB1-TLR4 signaling, NLRP3 inflammasome formation, and upregulation of pyroptosis markers caspase-1, IL-1β, IL-18, and the pyroptosis executor GSDMD.